Letter to the Editor

Issue: Ahead-of-Print Publication Date: 2026-10-16
Atypical syncope during plasma donation as the first manifestation of an obstructive hydrocephalus: Donor reaction reveals hydrocephalus

Massimo La Raja, Monica Marconi, Leonello Tacconi
Issue: Ahead-of-Print Publication Date: 2026-07-24
Patient Blood Management in the Emergency Department: reducing transfusions and anemia-related admissions at 6 months: PBM in Emergency Departments: 6-month impact

Giacomo Marchi, Fabio Chesini, Alice Vianello, Ciro Paolillo, Antonio Maccagnani, Domenico Girelli
Issue: Vol. 24 No. 5 (2026): Blood Transfusion 5-2026 (September-October) Publication Date: 2026-07-07
AI and transfusion medicine in Europe: why public leadership cannot wait: Public leadership for AI in transfusion medicine

Massimo La Raja, Vincenzo De Angelis, Giovanni Camisasca, Luis Larrea
Issue: Vol. 24 No. 4 (2026): Blood Transfusion 4-2026 (July-August) Publication Date: 2026-06-04
Oxygen delivery, hemodilution and transfusion in critical illness: an underrecognized safety signal in albumin randomized trials: N/A

Raffaele Mandarano, Stefano Romagnoli, Mayurathan Balachandran, Yahya Shehabi
Issue: Vol. 24 No. 4 (2026): Blood Transfusion 4-2026 (July-August) Publication Date: 2026-03-17
The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child

Samantha Pasca, Federica Fati, Clara Revetria, Stella Poda, Sonia Secchi
Issue: Vol. 24 No. 2 (2026): Blood Transfusion 2-2026 (March-April) Publication Date: 2025-11-27
No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction: No bleeding during dialysis catheter insertion with INR 3.2

Piotr Czempik, Tomasz Jaworski
Issue: Vol. 24 No. 2 (2026): Blood Transfusion 2-2026 (March-April) Publication Date: 2025-11-20
Molecularly confirmed para-Bombay (Ah) secretor phenotype with FUT1 c.328G>A and FUT2 c.357C>T mutations: first case report from India: Para-Bombay Ah secretor phenotype from India

Thamizhsurabi Arivazhagan, Tejaswi Chada, Srinivasa Rao Chunchu, Monali Lokhande, Rati Devendra
Issue: Vol. 23 No. 6 (2025): Blood Transfusion 6-2025 (November-December) Publication Date: 2025-04-15
Gender difference among blood donors: should laboratory ranges be changed? Gender difference in laboratory ranges

Samantha Pasca, Sonia Secchi, Luca Postal, Paola Boccagni
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia: Factor VIII concentrate rather than cryoprecipitate for Haemophilia

Mike Makris, Cedric Hermans
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Recommending defunct therapies is a safety risk for hemophilia: Therapies and safety risks in haemophilia

Glenn Pierce, Brian O'Mahony, Radoslaw Kaczmarek, Salome Mekhuzia, Mark Skinner
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action: Responses to comments on Cryo-PR listing on the WHO EML

Jay Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W. Martin Smid, Thierry Burnouf
Issue: Vol. 23 No. 3 (2025): Blood Transfusion 3-2025 (May-June) Publication Date: 2024-11-29
Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Alessandra Bernardi, Pierpaolo Berti, Elisabetta Cicchetti, Fabiola Landi, Ottavia Porzio
Issue: Vol. 23 No. 4 (2025): Blood Transfusion 4-2025 (July-August) Publication Date: 2024-11-29
Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

Chonghe Xu, Zhongqi Zhu, Mei Zhu, Wei Xu
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December) Publication Date: 2024-07-22
Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Marco Catarci
Issue: Vol. 22 No. 5 (2024): Blood Transfusion 5-2024 (September-October) Publication Date: 2024-05-23
Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Luca Collodel, Gianluca Gessoni, Tommaso Mancuso
Issue: Vol. 22 No. 3 (2024): Blood Transfusion 3-2024 (May-June) Publication Date: 2024-03-04
Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention: Thrombotic thrombocytopenic purpura: optimal management

Ingrid Parra-Salinas, Juan Rodríguez-García, Saioa Zalba-Marcos , José Antonio García-Erce
Issue: Vol. 22 No. 3 (2024): Blood Transfusion 3-2024 (May-June) Publication Date: 2024-03-04
Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment: .

Nadia Garcia Muñoz, Sandra Ortega Sanchez, Joan R Grifols
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-12-19
Establishment of a case registry that collaborates with a reference laboratory for blood group immunogenetics in Korea: Blood group immunogenetics case registry and laboratory

Dong Woo Shin, Yun Ji Hong, Kyoung Un Park
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-11-30
DENV outbreak in Italy: the impact on the national transfusion network: DENV outbreak in Italy: the impact on the national transfusion network

Ilaria Pati, Giulio Pisani, Flavia Riccardo, Giulietta Venturi, Vincenzo De Angelis
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-11-09
A potential food-related acute allergic transfusion reaction: Food-related allergic transfusion reaction

Kelly Johnson-Arbor, Colleen Gilstad, Richard Verstraete
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-10-24
Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study: PBM in bone marrow harvest

Caterina Giovanna Valentini, Idanna Innocenti, Claudio Pellegrino, Gaetano Draisci, Luciana Teofili
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-07-31
A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Yuyu Zhang, Dong Xiang
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-06-12
Significant neutropenia induced by metamizole dependent neutrophil antibodies: Metamizole and neutropenia

Brian R Curtis, Stefanie Jehle, Gregor Bein, Behnaz Bayat, Ulrich J Sachs
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August) Publication Date: 2023-04-13
Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy : Survey on blood donation

Massimiliano Copetti, Carmen Di Silvio, Rosanna Mangiarotti, Alessandra Vignoli, Laura Franzini
Issue: Vol. 17 No. 2 (2019): Blood Transfusion - 2 2019 (March-April) Publication Date: 2022-12-02
A case of dabigratan-related acute agranulocytosis

Ahmad Al-Khaffaf, Francesco Frattini, Cinzia Sissa, Elda Mimiola, Massimo Franchini
Issue: Vol. 20 No. 6 (2022): Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

Stephen M. Henry, Willy A. Flegel, Christof Weinstock
Issue: Vol. 20 No. 6 (2022): Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
COVID-19 vaccination, anticoagulation level and warfarin treatment

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Issue: Vol. 20 No. 6 (2022): Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

Elena Lotti, Alessandro Masi, Chiara Cappugi, Alessandra Fanelli, Lucia Mannini, Rossella Marcucci, Daniela Poli
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August) Publication Date: 2022-06-07
A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test: A novel RhD confirmatory test for WAIHA patients

Chunchen Yang, Jiewei Zheng, Ruiming Rong, Dong Xiang
Issue: Vol. 20 No. 3 (2022): Blood Transfusion - 3 2022 (May-June) Publication Date: 2021-09-22
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Federica Calò, Alessandra Di Fraia, Antonio Russo, Antonio Di Biase, Saverio Misso, Nicola Coppola
Issue: Vol. 20 No. 2 (2022): Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Antonio Ragusa, Alessandro Svelato, Matteo Bolcato
Issue: Vol. 20 No. 2 (2022): Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Matteo Bolcato, Ivo Beverina
Issue: Vol. 19 No. 2 (2021): Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-23
Making friends out of foes: novel therapeutic approaches for haemophilia

Catriona Mactier, Cedric Hermans
Issue: Vol. 19 No. 2 (2021): Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-22
Appropriate red cell transfusions are often avoidable through Patient Blood Management

Kevin M. Trentino, Hamish S. Mace, Michael F. Leahy, Frank M. Sanfilippo, Shannon L. Farmer, Kevin Murray
Issue: Vol. 19 No. 1 (2021): Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-11-12
On the association between the ABO blood group and COVID-19 susceptibility

Davide Golinelli
Issue: Vol. 19 No. 1 (2021): Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-10-09
Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Jay Ho Han, So-Yong Kwon, Dong Wook Jekarl
Issue: Vol. 18 No. 6 (2020): Blood Transfusion - 6 2020 (November-December) Publication Date: 2020-09-18
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Samantha Pasca, Ezio Zanon
Issue: Vol. 18 No. 5 (2020): Blood Transfusion - 5 2020 (September-October) Publication Date: 2020-07-29
Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Mehran Karimi, Sezaneh Haghpanah, Amin Shahsavani
Issue: Vol. 18 No. 4 (2020): Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Daniela Dragonetti, Giuseppe Guarini, Michele Pizzuti
Issue: Vol. 18 No. 4 (2020): Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Therapeutic choices in persons with haemophilia at the time of COVID-19

Antonio Coppola, Federica Riccardi, Annarita Tagliaferri
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Giuseppe Giannaccare, Marina Buzzi, Piera Versura
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Valentino Granero, Paola M. Manzini, Anna M. Bordiga
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Marco Cattaneo, Nuccia Morici
Issue: Vol. 18 No. 3 (2020): Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta, Armando Tripodi
Issue: Vol. 17 No. 1 (2019): Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

Albert Farrugia
Issue: Vol. 17 No. 1 (2019): Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Arturo Pereira, Julio del Río-Garma, José A. García-Erce
Issue: Vol. 17 No. 1 (2019): Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci
Issue: Vol. 17 No. 1 (2019): Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Albert Farrugia, Megha Bansal
Issue: Vol. 16 No. 1 (2018): Blood Transfusion - 1 2018 (January - February) Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Per Sandgren

Submit an Article

Announcements

Winter Closure

The Editorial Office will be closed from December 31 to January 7, 2026.

Season’s greetings to all our readers, authors, and reviewers.

SIMTI 2026

46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)

SETS 2026

35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).

Madrid, 4-6 June 2026.

Editorial Office Closure Notice

Please note that the BT Editorial Office will be closed until August 26, 2026.

During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.

Thank you for your understanding.

Best regards,
BT Editorial Office

Impact Factor 2025

We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Letter to the Editor

Atypical syncope during plasma donation as the first manifestation of an obstructive hydrocephalus: Donor reaction reveals hydrocephalus

Patient Blood Management in the Emergency Department: reducing transfusions and anemia-related admissions at 6 months: PBM in Emergency Departments: 6-month impact

AI and transfusion medicine in Europe: why public leadership cannot wait: Public leadership for AI in transfusion medicine

Oxygen delivery, hemodilution and transfusion in critical illness: an underrecognized safety signal in albumin randomized trials: N/A

The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child

No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction: No bleeding during dialysis catheter insertion with INR 3.2

Molecularly confirmed para-Bombay (Ah) secretor phenotype with FUT1 c.328G>A and FUT2 c.357C>T mutations: first case report from India: Para-Bombay Ah secretor phenotype from India

Gender difference among blood donors: should laboratory ranges be changed? Gender difference in laboratory ranges

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia: Factor VIII concentrate rather than cryoprecipitate for Haemophilia

Recommending defunct therapies is a safety risk for hemophilia: Therapies and safety risks in haemophilia

Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action: Responses to comments on Cryo-PR listing on the WHO EML

Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention: Thrombotic thrombocytopenic purpura: optimal management

Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment: .

Establishment of a case registry that collaborates with a reference laboratory for blood group immunogenetics in Korea: Blood group immunogenetics case registry and laboratory

DENV outbreak in Italy: the impact on the national transfusion network: DENV outbreak in Italy: the impact on the national transfusion network

A potential food-related acute allergic transfusion reaction: Food-related allergic transfusion reaction

Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study: PBM in bone marrow harvest

A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Significant neutropenia induced by metamizole dependent neutrophil antibodies: Metamizole and neutropenia

Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy : Survey on blood donation

A case of dabigratan-related acute agranulocytosis

Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

COVID-19 vaccination, anticoagulation level and warfarin treatment

Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test: A novel RhD confirmatory test for WAIHA patients

Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Making friends out of foes: novel therapeutic approaches for haemophilia

Appropriate red cell transfusions are often avoidable through Patient Blood Management

On the association between the ABO blood group and COVID-19 susceptibility

Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Therapeutic choices in persons with haemophilia at the time of COVID-19

Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

Banner

Identification of a novel ABOO.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABOO.01.01 allele with c.801G>T